BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17970647)

  • 1. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages.
    Caito S; Yang SR; Kode A; Edirisinghe I; Rajendrasozhan S; Phipps RP; Rahman I
    Antioxid Redox Signal; 2008 Feb; 10(2):253-60. PubMed ID: 17970647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
    Berry A; Balard P; Coste A; Olagnier D; Lagane C; Authier H; Benoit-Vical F; Lepert JC; Séguéla JP; Magnaval JF; Chambon P; Metzger D; Desvergne B; Wahli W; Auwerx J; Pipy B
    Eur J Immunol; 2007 Jun; 37(6):1642-52. PubMed ID: 17458857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/macrophages of patients with coronary heart disease.
    Amoruso A; Gunella G; Rondano E; Bardelli C; Fresu LG; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
    Br J Pharmacol; 2009 Nov; 158(5):1276-84. PubMed ID: 19814730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
    Lakshmi SP; Reddy AT; Zhang Y; Sciurba FC; Mallampalli RK; Duncan SR; Reddy RC
    J Biol Chem; 2014 Mar; 289(10):6383-6393. PubMed ID: 24368768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.
    Bardelli C; Amoruso A; Federici Canova D; Fresu L; Balbo P; Neri T; Celi A; Brunelleschi S
    Br J Pharmacol; 2012 Feb; 165(3):716-28. PubMed ID: 21745193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
    Hovsepian E; Penas F; Goren NB
    Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles.
    Neri T; Armani C; Pegoli A; Cordazzo C; Carmazzi Y; Brunelleschi S; Bardelli C; Breschi MC; Paggiaro P; Celi A
    Eur Respir J; 2011 Jun; 37(6):1494-502. PubMed ID: 21148223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
    Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Park SK
    Nephrol Dial Transplant; 2006 Aug; 21(8):2096-105. PubMed ID: 16728429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
    Woster AP; Combs CK
    J Neurochem; 2007 Oct; 103(1):67-76. PubMed ID: 17573821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
    Ray DM; Bernstein SH; Phipps RP
    Clin Immunol; 2004 Nov; 113(2):203-13. PubMed ID: 15451478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.
    Yin Y; Hou G; Li E; Wang Q; Kang J
    Respir Res; 2014 Mar; 15(1):28. PubMed ID: 24612634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.